Ipamorelin
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. It stimulates growth hormone release with minimal effect on cortisol or prolactin, making it one of the cleaner GH-releasing peptides available.
Quick facts
- Half-life
- ~2 hours
- Administration
- Subcutaneous injection
- Primary use
- Growth hormone release, recovery
How it works
Ipamorelin mimics ghrelin and binds to the GHS-R1a receptor in the pituitary gland, triggering a selective pulse of growth hormone. Unlike other GHRPs, it does not significantly raise cortisol or prolactin levels.
Reported benefits
- Clean, selective growth hormone release
- Improved muscle recovery and lean mass
- Better sleep quality and depth
- Minimal side effect profile compared to other GHRPs
Typical dosing protocol
Dosing
100–300 mcg per injection, 2–3x daily (often combined with CJC-1295)
Cycle length
8–12 weeks
Dosing information is for educational reference only. Individual needs vary. Always consult a healthcare professional.
Safety & considerations
Generally well-tolerated. May cause mild water retention or headaches. Not approved for human use in the UK. Consult a healthcare professional before use.
Tags
Important: All content is for informational purposes only. Not medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.